Skip to content
PubMed This is a summary of 76 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 76 referenced papers

Top Authors

Cinzia Milito
Sapienza University of Rome
Giuseppe Spadaro
University of Naples Federico II
Charlotte Cunningham‐Rundles
Icahn School of Medicine at Mount Sinai
Kathleen E. Sullivan
Children's Hospital of Philadelphia
Amit Kumar Rawat
Post Graduate Institute of Medical Education and Research
Klaus Warnatz
University of Freiburg
Alessandro Plebani
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Francesco Cinetto
University of Padua
Leif G. Hanitsch
Humboldt-Universität zu Berlin
Francisco A. Bonilla
Boston Children's Hospital

Top Institutions

Ranked by publications Top 10 institutions
04

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Brescia, Italy

27 papers
06

Post Graduate Institute of Medical Education and Research

Chandigarh, India

13 papers

References

References (76)
  1. 1

    [X-linked agammaglobulinemia: experience in a Portuguese hospital].

    Fernandes A, Guedes M, Vasconcelos J, et al.

    Anales de pediatria (Barcelona, Spain : 2003) 2015; (82(3)):166-71.

    PMID: 25443324
  2. 2

    Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy.

    Bearden D, Collett M, Quan PL, et al.

    The journal of allergy and clinical immunology. In practice 2016; (4(6)):1059-1065 doi:10.1016/j.jaip.2015.12.015.

    PMID: 26883540
  3. 3

    X-linked Agammaglobulinemia.

    Suri D, Rawat A, Singh S

    Indian journal of pediatrics 2016; (83(4)):331-7 doi:10.1007/s12098-015-2024-8.

    PMID: 26909497
  4. 4

    Intravenous and subcutaneous immunoglobulin G replacement therapy.

    Bonilla FA

    Allergy and asthma proceedings 2016; (37(6)):426-431 doi:10.2500/aap.2016.37.3987.

    PMID: 27931296
  5. 5

    Gastrointestinal Manifestations in X-linked Agammaglobulinemia.

    Barmettler S, Otani IM, Minhas J, et al.

    Journal of clinical immunology 2017; (37(3)):287-294 doi:10.1007/s10875-017-0374-x.

    PMID: 28236219
  6. 6

    Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children - 34-year experience of a single center.

    Pac M, Bernatowska EA, Kierkuś J, et al.

    Archives of medical science : AMS 2017; (13(2)):412-417 doi:10.5114/aoms.2016.60338.

    PMID: 28261296
  7. 7

    Common Variable Immunodeficiency and Liver Involvement.

    Song J, Lleo A, Yang GX, et al.

    Clinical reviews in allergy & immunology 2018; (55(3)):340-351 doi:10.1007/s12016-017-8638-z.

    PMID: 28785926
  8. 8

    Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach.

    Pecoraro A, Crescenzi L, Granata F, et al.

    International immunopharmacology 2017; (52()):136-142 doi:10.1016/j.intimp.2017.09.005.

    PMID: 28898770
  9. 9

    Autosomal Recessive Agammaglobulinemia - first case with a novel TCF3 mutation from Pakistan.

    Qureshi S, Sheikh MDA, Qamar FN

    Clinical immunology (Orlando, Fla.) 2019; (198()):100-101 doi:10.1016/j.clim.2018.07.016.

    PMID: 30063982
  10. 10

    The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation.

    Baumann U, Routes JM, Soler-Palacín P, Jolles S

    Frontiers in immunology 2018; (9()):1837 doi:10.3389/fimmu.2018.01837.

    PMID: 30147696
  11. 11

    Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group.

    Schütz K, Alecsandru D, Grimbacher B, et al.

    Journal of clinical immunology 2019; (39(1)):45-54 doi:10.1007/s10875-018-0577-9.

    PMID: 30547383
  12. 12

    Concomitant diagnosis of immune deficiency and Pseudomonas sepsis in a 19 month old with ecthyma gangrenosum by host whole-genome sequencing.

    Sanford E, Farnaes L, Batalov S, et al.

    Cold Spring Harbor molecular case studies 2018; (4(6)) doi:10.1101/mcs.a003244.

    PMID: 30559311
  13. 13

    X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world.

    El-Sayed ZA, Abramova I, Aldave JC, et al.

    The World Allergy Organization journal 2019; (12(3)):100018 doi:10.1016/j.waojou.2019.100018.

    PMID: 30937141
  14. 14

    Factors Beyond Lack of Antibody Govern Pulmonary Complications in Primary Antibody Deficiency.

    Weinberger T, Fuleihan R, Cunningham-Rundles C, Maglione PJ

    Journal of clinical immunology 2019; (39(4)):440-447 doi:10.1007/s10875-019-00640-5.

    PMID: 31089938
  15. 15

    EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.

    van Dongen JJM, van der Burg M, Kalina T, et al.

    Frontiers in immunology 2019; (10()):1271 doi:10.3389/fimmu.2019.01271.

    PMID: 31263462
  16. 16

    Iatrogenic antibody deficiency from B-cell targeted therapies in autoimmune rheumatic diseases.

    Wijetilleka S, Jayne D, Mukhtyar C, Karim MY

    Lupus science & medicine 2019; (6(1)):e000337 doi:10.1136/lupus-2019-000337.

    PMID: 31413852
  17. 17

    A Novel BTK Gene Mutation in a Child With Atypical X-Linked Agammaglobulinemia and Recurrent Hemophagocytosis: A Case Report.

    Han SP, Lin YF, Weng HY, et al.

    Frontiers in immunology 2019; (10()):1953 doi:10.3389/fimmu.2019.01953.

    PMID: 31481959
  18. 18

    [Genetic diagnosis of patients with primary agammaglobulinemia treated at third level peruvian centers].

    Matos-Benavides E, García-Gomero D, Inocente-Malpartida R, et al.

    Revista peruana de medicina experimental y salud publica 2019; (36(4)):664-669 doi:10.17843/rpmesp.2019.364.4311.

    PMID: 31967259
  19. 19

    Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases: A Single Center Experience.

    Kwon WK, Choi S, Kim HJ, et al.

    Allergy, asthma & immunology research 2020; (12(2)):292-305 doi:10.4168/aair.2020.12.2.292.

    PMID: 32009323
  20. 20

    Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies.

    Pecoraro A, Ricci S, Vultaggio A, et al.

    Clinical drug investigation 2020; (40(3)):279-286 doi:10.1007/s40261-020-00885-8.

    PMID: 32036588
  21. 21

    Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia.

    Fekrvand S, Yazdani R, Olbrich P, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020; (31(4)):405-417 doi:10.1111/pai.13228.

    PMID: 32058651
  22. 22

    Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia: Implications for Genetic Counseling.

    Rivière JG, Franco-Jarava C, Martínez-Gallo M, et al.

    Frontiers in immunology 2020; (11()):46 doi:10.3389/fimmu.2020.00046.

    PMID: 32117230
  23. 23

    Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality.

    Lougaris V, Soresina A, Baronio M, et al.

    The Journal of allergy and clinical immunology 2020; (146(2)):429-437 doi:10.1016/j.jaci.2020.03.001.

    PMID: 32169379
  24. 24

    Bronchiectasis in Primary Antibody Deficiencies: A Multidisciplinary Approach.

    Wall LA, Wisner EL, Gipson KS, Sorensen RU

    Frontiers in immunology 2020; (11()):522 doi:10.3389/fimmu.2020.00522.

    PMID: 32296433
  25. 25

    Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.

    Soresina A, Moratto D, Chiarini M, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020; (31(5)):565-569 doi:10.1111/pai.13263.

    PMID: 32319118
  26. 26

    Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management.

    Pashangzadeh S, Yazdani R, Nazari F, et al.

    Endocrine, metabolic & immune disorders drug targets 2020; (20(9)):1434-1447 doi:10.2174/1871530320666200508114349.

    PMID: 32384040
  27. 27

    Evaluation of pulmonary findings in patients with humoral immunodeficiency.

    Karalı Z, Karalı Y, Çekiç Ş, et al.

    Turk pediatri arsivi 2020; (55(2)):174-183 doi:10.14744/TurkPediatriArs.2020.46656.

    PMID: 32684763
  28. 28

    Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline.

    Hanitsch L, Baumann U, Boztug K, et al.

    European journal of immunology 2020; (50(10)):1432-1446 doi:10.1002/eji.202048713.

    PMID: 32845010
  29. 29

    Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency.

    Saettini F, Poli C, Vengoechea J, et al.

    Blood 2021; (137(4)):493-499 doi:10.1182/blood.2020006441.

    PMID: 32905580
  30. 30

    The Development of a New Questionnaire to Measure the Burden of Immunoglobulin Treatment in Patients with Primary Immunodeficiencies: The IgBoT-35.

    Jones GL, Williams K, Edmondson-Jones M, et al.

    Patient preference and adherence 2020; (14()):1567-1584 doi:10.2147/PPA.S234669.

    PMID: 32982185
  31. 31

    Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.

    Yeh YH, Hsieh MY, Lee WI, et al.

    Frontiers in immunology 2020; (11()):2001 doi:10.3389/fimmu.2020.02001.

    PMID: 33013854
  32. 32

    Infection Phenotypes Among Patients with Primary Antibody Deficiency Mined from a US Patient Registry.

    Pickett G, Motazedi T, Kutac C, et al.

    Journal of clinical immunology 2021; (41(2)):374-381 doi:10.1007/s10875-020-00916-1.

    PMID: 33205244
  33. 33

    Ecthyma gangrenosum due to Pseudomonas aeruginosa sepsis as initial manifestation of X-linked agammaglobulinemia: a case report.

    Huang H, Bai K, Fu Y, et al.

    BMC pediatrics 2020; (20(1)):540 doi:10.1186/s12887-020-02436-8.

    PMID: 33261572
  34. 34

    X-Linked Agammaglobulinemia With Chronic Meningoencephalitis: A Diagnostic Challenge.

    Saini AG, Radotra BD, Bhattarai D, et al.

    Indian pediatrics 2021; (58(2)):169-173.

    PMID: 33632949
  35. 35

    X-linked agammaglobulinemia: ınvestigation of clinical and laboratory findings, novel gene mutations and prevention of ınfective complications in long-term follow-up.

    Yıldırım İ, Topyıldız E, Bilgin RBG, et al.

    American journal of clinical and experimental immunology 2021; (10(1)):37-43.

    PMID: 33815962
  36. 36

    Current Spectrum of Infections in Patients with X-Linked Agammaglobulinemia.

    Paccoud O, Mahlaoui N, Moshous D, et al.

    Journal of clinical immunology 2021; (41(6)):1266-1271 doi:10.1007/s10875-021-01043-1.

    PMID: 33880703
  37. 37

    Vaccination in PADs.

    Milito C, Soccodato V, Collalti G, et al.

    Vaccines 2021; (9(6)) doi:10.3390/vaccines9060626.

    PMID: 34207916
  38. 38

    Common Variable Immunodeficiency and Autoimmune Diseases: A Retrospective Study of 95 Adult Patients in a Single Tertiary Care Center.

    Mormile I, Punziano A, Riolo CA, et al.

    Frontiers in immunology 2021; (12()):652487 doi:10.3389/fimmu.2021.652487.

    PMID: 34290696
  39. 39

    An X-linked agammaglobulinemia (XLA) patient with fever and disturbance of consciousness: infection with Torque teno virus?

    Liu H, Zhao J, Yang L, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022; (115()):26-29 doi:10.1016/j.ijid.2021.11.041.

    PMID: 34863924
  40. 40

    Clinical, immunological and genomic characteristics of children with X-linked agammaglobulinemia from Kerala, South India.

    Madathil Govindaraj G, Jain A, Edavazhippurath A, et al.

    Human immunology 2022; (83(4)):335-345 doi:10.1016/j.humimm.2022.01.003.

    PMID: 35074268
  41. 41

    Clinical and laboratory observation on immunoglobulin replacement therapy switching from an intravenous to a subcutaneous route in a Malaysian X-linked agammaglobulinemia patient.

    Adli A, Wahab AA, Abdul Latiff AH, et al.

    The Medical journal of Malaysia 2022; (77(1)):95-97.

    PMID: 35087003
  42. 42

    Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.

    van Leeuwen LPM, GeurtsvanKessel CH, Ellerbroek PM, et al.

    The Journal of allergy and clinical immunology 2022; (149(6)):1949-1957 doi:10.1016/j.jaci.2022.04.002.

    PMID: 35421449
  43. 43

    Impact of Primary Immunodeficiency Diseases on the Life Experiences of Patients in Malaysia From the Caregivers' Perspective: A Qualitative Study.

    Ahmed Meelad R, Abd Hamid IJ, Hashim IF, et al.

    Frontiers in pediatrics 2022; (10()):846393 doi:10.3389/fped.2022.846393.

    PMID: 35433547
  44. 44

    Multiple Breath Washout for Early Assessment of Pulmonary Complications in Patients With Primary Antibody Deficiencies: An Observational Study in Pediatric Age.

    Secchi T, Baselli LA, Russo MC, et al.

    Frontiers in pediatrics 2022; (10()):773751 doi:10.3389/fped.2022.773751.

    PMID: 35656375
  45. 45

    Global Expansion of Jeffrey's Insights: Jeffrey Modell Foundation's Genetic Sequencing Program for Primary Immunodeficiency.

    Quinn J, Modell V, Johnson B, et al.

    Frontiers in immunology 2022; (13()):906540 doi:10.3389/fimmu.2022.906540.

    PMID: 35757720
  46. 46

    Response to mRNA COVID-19 vaccination in three XLA patients.

    Squire JD, Joshi AY

    Vaccine 2022; (40(36)):5299-5301 doi:10.1016/j.vaccine.2022.07.046.

    PMID: 35934578
  47. 47

    Meningoencephalitis in primary antibody deficiency: Our experience from northwest India.

    Jindal AK, Chaudhary H, Tyagi R, et al.

    Journal of neuroimmunology 2022; (371()):577952 doi:10.1016/j.jneuroim.2022.577952.

    PMID: 36030644
  48. 48

    Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms.

    Hanitsch LG

    Current opinion in allergy and clinical immunology 2022; (22(6)):335-342 doi:10.1097/ACI.0000000000000856.

    PMID: 36165423
  49. 49

    Cytomegalovirus Pneumonia in a Patient with X-Linked Agammaglobulinemia: A Case Report.

    Wong YX, Shyur SD

    Medicina (Kaunas, Lithuania) 2022; (58(10)) doi:10.3390/medicina58101457.

    PMID: 36295618
  50. 50

    A Registry Study of 240 Patients with X-Linked Agammaglobulinemia Living in the USA.

    Hernandez-Trujillo V, Zhou C, Scalchunes C, et al.

    Journal of clinical immunology 2023; (43(6)):1468-1477 doi:10.1007/s10875-023-01502-x.

    PMID: 37219739
  51. 51

    Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies.

    Mizera D, Dziedzic R, Drynda A, et al.

    Frontiers in immunology 2023; (14()):1275892 doi:10.3389/fimmu.2023.1275892.

    PMID: 37901210
  52. 52

    Pulmonary Computed Tomography Screening Frequency in Primary Antibody Deficiency.

    Smits BM, Boland SL, Hol ME, et al.

    The journal of allergy and clinical immunology. In practice 2024; (12(4)):1037-1048.e3 doi:10.1016/j.jaip.2023.12.047.

    PMID: 38182096
  53. 53

    Knowledge, awareness, and perception on genetic testing for primary immunodeficiency disease among parents in Malaysia: a qualitative study.

    Ahmad Azahari AHS, Hakim Zada F, Ismail IH, et al.

    Frontiers in immunology 2023; (14()):1308305 doi:10.3389/fimmu.2023.1308305.

    PMID: 38283358
  54. 54

    Psychosocial Evaluation of Adults with Primary Immunodeficiency.

    Gumusburun R, Altay S, Cengiz H, et al.

    Journal of clinical immunology 2024; (44(3)):71 doi:10.1007/s10875-024-01671-3.

    PMID: 38411715
  55. 55

    B-cells absence in patients diagnosed as inborn errors of immunity: a registry-based study.

    Khoshnevisan R, Hassanzadeh S, Klein C, et al.

    Immunogenetics 2024; (76(3)):189-202 doi:10.1007/s00251-024-01342-y.

    PMID: 38683392
  56. 56

    Fluoxetine Successfully Treats Intracranial Enterovirus E18 Infection in a Patient with CD79a Deficiency Arising from Segmental Uniparental Disomy of Chromosome 19.

    Yu L, Zhang Y, Li W, et al.

    Journal of clinical immunology 2024; (44(6)):137 doi:10.1007/s10875-024-01740-7.

    PMID: 38805163
  57. 57

    Impaired B-cell function in ERCC2 deficiency.

    Rossmanith R, Sauerwein K, Geier CB, et al.

    Frontiers in immunology 2024; (15()):1423141 doi:10.3389/fimmu.2024.1423141.

    PMID: 39055713
  58. 58

    Exclusive Characteristics of the p.E555K Dominant-Negative Variant in Autosomal Dominant E47 Deficiency.

    Utsumi T, Tsumura M, Yashiro M, et al.

    Journal of clinical immunology 2024; (44(7)):167 doi:10.1007/s10875-024-01758-x.

    PMID: 39073655
  59. 59

    Expanding the Clinical Phenotype with CD79A Mutation and Refractory Helicobacter Bilis Infection.

    Sil A, Basu S, Arora K, et al.

    Journal of clinical immunology 2024; (44(8)):187 doi:10.1007/s10875-024-01792-9.

    PMID: 39215847
  60. 60

    Immunoglobulin therapy for immunodeficiency.

    Wilson BE, Freeman CM

    Allergy and asthma proceedings 2024; (45(5)):364-370 doi:10.2500/aap.2024.45.240053.

    PMID: 39294913
  61. 61

    Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies.

    Goede JS, Baumann CK, Cathomas R, et al.

    Swiss medical weekly 2024; (154()):3559 doi:10.57187/s.3559.

    PMID: 39462479
  62. 62

    Outcomes of X-Linked Agammaglobulinaemia Patients.

    Shillitoe B, Duque JSR, Lai SHY, et al.

    Journal of clinical immunology 2024; (45(1)):40.

    PMID: 39541002
  63. 63

    Non-infectious pulmonary and gastrointestinal manifestations in primary antibody deficiencies: lessons for the clinic.

    Franco M, Buso H, Carfora F, et al.

    Expert review of clinical immunology 2025; (21(9)):1229-1249 doi:10.1080/1744666X.2025.2556435.

    PMID: 40957411
  64. 64

    Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter Study.

    Stenlander C, Lindahl H, Wahren-Borgström E, et al.

    Journal of clinical immunology 2025; (45(1)):161.

    PMID: 41240154
  65. 65

    Clinical relevant Bruton's X-linked tyrosine kinase deficiency in a female with extreme X-chromosome inactivation.

    NoorSaeed SM, Alrafiaah AS, Alghamdi M, et al.

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2025; (22(1)):4 doi:10.1186/s13223-025-01002-0.

    PMID: 41327272
  66. 66

    A rare cause of cellulitis and bacteremia by Achromobacter xylosoxidans in a patient with X-linked agammaglobulinemia: a case report.

    Wagle L, Aryal E, Bruges P, et al.

    Annals of medicine and surgery (2012) 2025; (87(12)):8940-8943 doi:10.1097/MS9.0000000000004093.

    PMID: 41377235
  67. 67

    Pulmonary Manifestations of Inborn Errors of Immunity: Diagnostic and Therapeutic Insights.

    Napiorkowska-Baran K, Cofta S, Treichel P, et al.

    Life (Basel, Switzerland) 2025; (15(12)) doi:10.3390/life15121838.

    PMID: 41465777
  68. 68

    A rare case of TCF3-related agammaglobulinemia in a child with recurrent Haemophilus influenzae bacteremia.

    Fang Y, Dubrocq G

    Proceedings (Baylor University. Medical Center) 2026; (39(1)):152-154 doi:10.1080/08998280.2025.2552088.

    PMID: 41487546
  69. 69

    Vulnerability beyond infection: Effects of peer victimization on quality of life and psychosocial well-being in inborn errors of immunity.

    Meric Z, Durcan G, Coban ZB, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2026; (37(3)):e70318 doi:10.1111/pai.70318.

    PMID: 41800593
  70. 70

    A case report of X-linked agammaglobulinemia complicated with necrotic pneumonia.

    Zhang X, Zhu J

    Translational pediatrics 2026; (15(4)):160 doi:10.21037/tp-2025-353.

    PMID: 42158683
  71. 71

    Adult Sibling Cases of Cutaneous Botryomycosis Leading to the Diagnosis of X-Linked Agammaglobulinemia.

    Takeuchi M, Kaku Y, Hashikawa K, et al.

    The American Journal of dermatopathology 2026; (48(8)):632-636 doi:10.1097/DAD.0000000000003306.

    PMID: 42358014
  72. 72

    Bronchiectasis in Inborn Errors of Immunity: Prevalence, Predictors, and Cardiopulmonary Complications in a Genetically Characterized Cohort.

    Marangu-Boore D, Myint-Hpu K, Kang E, et al.

    Journal of clinical immunology 2026; (46(1)).

    PMID: 42414785
  73. 73

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994
  74. 74

    Severe Polymicrobial Pneumonia With Septicemia After Interruption of Immunoglobulin Replacement in X-Linked Agammaglobulinemia: A Case Report.

    Tran HD, Vo QH, Nguyen NP

    Case reports in immunology 2026; (2026()):7974374 doi:10.1155/crii/7974374.

    PMID: 42729739
  75. 75

    Clinical and genetic characterization of X-linked agammaglobulinemia in a Colombian cohort.

    Olaya Hernández M, Triviño Arias J, Arias Valderrama O, et al.

    The World Allergy Organization journal 2026; (19(9)):101441 doi:10.1016/j.waojou.2026.101441.

    PMID: 42733469
  76. 76

    Frequency of depression and anxiety in patients with inborn errors of immunity: a cross-sectional study.

    Wolff LJ, Witte T, Kahl KG, et al.

    BMC psychiatry 2026; (26(1)).

    PMID: 42745244